Kwality Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	35.92	120.2	22.58	30.7	91.35
Short-Term Investments	-	27.35	36.86	42.94	38.16
Cash & Short-Term Investments	35.92	147.55	59.44	73.63	129.51
Cash Growth	-75.65%	148.25%	-19.28%	-43.14%	26.40%
Accounts Receivable	2,801	1,543	1,144	716.94	691.31
Other Receivables	88.2	127.94	163.82	68.96	88.01
Receivables	2,889	1,671	1,308	785.91	779.32
Inventory	782.52	834.66	783.87	863.15	533.6
Other Current Assets	349.6	184.57	275.9	349.31	835.76
Total Current Assets	4,057	2,838	2,427	2,072	2,278
Property, Plant & Equipment	1,667	1,440	1,391	1,348	1,039
Long-Term Investments	-	-	-	9.32	7.82
Other Intangible Assets	58.45	17.07	-	-	-
Long-Term Deferred Tax Assets	25.02	16.15	0.25	-	-
Other Long-Term Assets	114.52	161.88	124.4	107.12	81.08
Total Assets	5,922	4,473	3,942	3,536	3,406
Accounts Payable	1,017	557.93	443.17	351.92	345.15
Accrued Expenses	3.93	12.73	26.24	8.48	5.58
Short-Term Debt	1,011	973.26	785.59	629.61	337.23
Current Portion of Long-Term Debt	-	-	-	-	91.8
Current Income Taxes Payable	81.97	59.31	65.21	64.84	410
Other Current Liabilities	141.83	91.82	198.29	204.6	205.1
Total Current Liabilities	2,255	1,695	1,519	1,259	1,395
Long-Term Debt	294	151.19	195.6	273.03	202.88
Pension & Post-Retirement Benefits	11.83	2.52	2.16	9.03	7.53
Long-Term Deferred Tax Liabilities	-	-	-	4.11	2.75
Other Long-Term Liabilities	61.85	0	-	-	-
Total Liabilities	2,623	1,849	1,716	1,546	1,608
Common Stock	103.76	103.76	103.76	103.76	103.76
Additional Paid-In Capital	-	84.68	84.68	84.68	-
Retained Earnings	-	2,444	2,046	1,809	1,700
Comprehensive Income & Other	3,212	7.71	7.63	8	8.04
Total Common Equity	3,316	2,640	2,242	2,005	1,811
Minority Interest	-16.75	-16.52	-16.28	-14.47	-13.55
Shareholders' Equity	3,299	2,624	2,226	1,991	1,798
Total Liabilities & Equity	5,922	4,473	3,942	3,536	3,406
Total Debt	1,305	1,124	981.19	902.64	631.92
Net Cash (Debt)	-1,269	-976.9	-921.75	-829	-502.41
Net Cash Per Share	-122.26	-94.15	-88.83	-79.89	-48.42
Filing Date Shares Outstanding	10.37	10.38	10.38	10.38	10.38
Total Common Shares Outstanding	10.37	10.38	10.38	10.38	10.38
Working Capital	1,802	1,143	908.39	812.54	883.33
Book Value Per Share	319.66	254.48	216.08	193.25	174.58
Tangible Book Value	3,258	2,623	2,242	2,005	1,811
Tangible Book Value Per Share	314.02	252.83	216.08	193.25	174.58
Buildings	-	577.85	519.84	281.53	228.11
Machinery	-	1,515	1,357	1,272	966.75
Construction In Progress	-	-	-	142.92	121.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.